Dark

Check out our Dark Pool Levels

BPUSDT
BP / Tether USD
crypto Composite

Inactive

Jun 5, 2023 3:50:00 AM EDT

0.000579USDT-35.667%(-0.000321)11,955,3570

Overview Historical DepthNews

Composite
0.00 HitBTC
0.00

Jan 28, 2022

01:20PM EST Profiting Off Putin's Play Benzinga

Jan 24, 2022

09:00AM EST US Secretary of Energy Jennifer Granholm to Address CERAWeek by IHS Markit in Houston, March 7-11 Business Wire

Jan 12, 2022

07:28AM EST Infosys: Revenue guidance for FY22 revised upwards to 19.5%-20.0%, powered by PR Newswire

Jan 4, 2022

10:14AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022 Benzinga

Dec 22, 2021

10:08AM EST CERAWeek by IHS Markit 2022 to Convene Energy CEOs, Government Officials, and Business and Technology Leaders in Houston, March 7-11 Business Wire

Nov 30, 2021

09:05AM EST JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical conditions GlobeNewswire Inc

Oct 27, 2021

07:02AM EDT $0.30 Up 30%, And $0.31 On A Non-GAAP Basis, Up 35% Compared To The Year-Ago Quarter On Good Loan Growth, Higher PPNR, A Stable Net Interest Margin, And Strong Deposit Growth PR Newswire

Oct 26, 2021

09:05AM EDT JATENZO (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical conditions GlobeNewswire Inc

Oct 15, 2021

10:15AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021 Benzinga

Oct 14, 2021

09:05AM EDT JATENZO (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical conditions GlobeNewswire Inc

Sep 16, 2021

09:05AM EDT Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to the wider class of mitochondrial diseases GlobeNewswire Inc

Sep 9, 2021

12:46PM EDT Businesscombination with Blue WaterAcquisitionCorp., a specialpurpose acquisitioncompany, completed onSeptember 9, 2021 GlobeNewswire Inc

Share